project id: TCGA-LGG; case submitter id: TCGA-FG-A70Z; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.81; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.22; rna integrity number: 7.5; age at index: 53; days to birth: -19717; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1958; age at diagnosis: 19717; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 328.0; icd 10 code: C71.0; last known disease status: not reported; morphology: 9382/3; primary diagnosis: Mixed glioma; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cerebrum; synchronous malignancy: No; tissue or organ of origin: Cerebrum; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 720; days to sample procurement: 0; initial weight: 300.0; portion submitter id: TCGA-FG-A70Z-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 10.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0;